By the Price of Business Show, a Media Partner
Recently Kevin Price, TTUSA Editor at Large and Host of the nationally syndicated Price of Business show recently interviewed Ernest Wong, PhD, MBA, and President and CEO of an innovative company called NervGen. According to its website, “NervGen is restoring life’s potential by creating innovative solutions for the treatment of nerve damage.NervGen’s core technology targets protein tyrosine phosphatase sigma (PTPσ), a neural receptor that impedes nerve regeneration. Inhibition of the PTPσ receptor has been shown to promote regeneration of damaged nerves and improvement of nerve function in animal models for various medical conditions. A series of receptor antagonists have been identified including a lead candidate ready for clinical development. NervGen plans to advance the lead candidate into the clinic initially for the treatment of spinal cord injury while exploiting the technology to identify additional therapeutic candidates for other related medical conditions.”
Listen to the interview in its entirety here:
